Fund shareholders of Aligos Therapeutics Inc
ISIN US01626L2043 · United States · LEI 549300UU2UJIKJYX0S67
- Fund shareholders
- 12
- Of which ETFs
- 2 10 other funds
- Value held
- 1.7M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 126,970 | 943.4K $ | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 46,948 | 348.8K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 26,779 | 188.3K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 7,553 | 53.1K $ | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 6,141 | 43.2K $ | as of Feb 28, 2026 ↗ | |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 4,344 | 32.3K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 3,347 | 20K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 1,879 | 13.2K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 1,427 | 10K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 1,172 | 7K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 760 | 5.3K $ | as of Feb 28, 2026 ↗ | |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 332 | 2.3K $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 12 | +1 | 227,652 | +5.6 % |
| 2026Q1 | 11 | 0 | 215,586 | -0.6 % |
| 2025Q4 | 11 | +1 | 216,969 | +22.2 % |
| 2025Q3 | 10 | -9 | 177,488 | -4.2 % |
| 2025Q2 | 19 | +7 | 185,187 | +57.5 % |
| 2025Q1 | 12 | +2 | 117,558 | +45.9 % |
| 2024Q4 | 10 | 80,579 |
Institutional managers
31 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Deep Track Capital, LP | 444,110 | 3.3M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 412,000 | 3.1M $ | as of Mar 31, 2026 |
| Sio Capital Management, LLC | 327,237 | 2.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 267,135 | 2M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 229,754 | 1.7M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 177,362 | 1.3M $ | as of Mar 31, 2026 |
| SummitTX Capital, L.P. | 148,799 | 1.1M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 100,450 | 746.3K $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 83,055 | 617.1K $ | as of Mar 31, 2026 |
| HHLR ADVISORS, LTD. | 76,247 | 566.5K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 54,311 | 403.5K $ | as of Mar 31, 2026 |
| LPL Financial LLC | 51,500 | 382.6K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 49,975 | 371.5K $ | as of Mar 31, 2026 |
| UBS Group AG | 37,061 | 275.4K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 23,093 | 171.6K $ | as of Mar 31, 2026 |
| Verition Fund Management LLC | 18,887 | 140.3K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 14,196 | 105.5K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 13,040 | 96.9K $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 10,978 | 81.6K $ | as of Mar 31, 2026 |
| Quadrature Capital Ltd | 10,822 | 80.4K $ | as of Mar 31, 2026 |
| Rockefeller Capital Management L.P. | 10,000 | 74.3K $ | as of Mar 31, 2026 |
| Golden State Wealth Management, LLC | 2,674 | 19.9K $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 2,125 | 16K $ | as of Mar 31, 2026 |
| Federation des caisses Desjardins du Quebec | 950 | 7.1K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 700 | 5.2K $ | as of Mar 31, 2026 |
Declared shareholders of Aligos Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Lawrence M. Blatt | 5.60 % | 316,228 | as of Jun 16, 2026 · SCHEDULE 13D |
| Woodline Partners LP | 4.40 % | 239,362 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Aligos Therapeutics Inc". https://titelia.com/en/stocks/aligos-therapeutics-inc-US01626L2043